SignatureFD’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.96K Buy
284
+58
+26% +$648 ﹤0.01% 3042
2026
Q1
$2.69K Hold
226
﹤0.01% 2975
2025
Q4
$2.25K Sell
226
-488
-68% -$4.66K ﹤0.01% 2936
2025
Q3
$6.39K Buy
714
+400
+127% +$3.7K ﹤0.01% 2570
2025
Q2
$2.96K Buy
314
+88
+39% +$776 ﹤0.01% 2755
2025
Q1
$2.45K Hold
226
﹤0.01% 2820
2024
Q4
$2.15K Hold
226
﹤0.01% 2845
2024
Q3
$2.54K Hold
226
﹤0.01% 2776
2024
Q2
$2.26K Sell
226
-24
-10% -$244 ﹤0.01% 2731
2024
Q1
$2.88K Sell
250
-1,142
-82% -$9.7K ﹤0.01% 2696
2023
Q4
$10.1K Buy
+1,392
New +$11K ﹤0.01% 2251
2023
Q3
Sell
-64
Closed -$779 3197
2023
Q2
$779 Buy
64
+3
+5% +$33 ﹤0.01% 3018
2023
Q1
$758 Sell
61
-431
-88% -$7.93K ﹤0.01% 3041
2022
Q4
$9.46K Buy
492
+7
+1% +$148 ﹤0.01% 2179
2022
Q3
$9K Buy
485
+103
+27% +$2.12K ﹤0.01% 2115
2022
Q2
$7K Sell
382
-4
-1% -$65 ﹤0.01% 2268
2022
Q1
$6K Buy
386
+326
+543% +$5.86K ﹤0.01% 2376
2021
Q4
$1K Buy
60
+14
+30% +$329 ﹤0.01% 2860
2021
Q3
$1K Buy
+46
New +$1.11K ﹤0.01% 2760

Other funds holding AHCO

SignatureFD's AHCO Position: Q2 2026 in Review

SignatureFD increased its AdaptHealth (AHCO) stake by 26% in Q2 2026, buying an estimated $648 and bringing the position to 284 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #3042.

SignatureFD first reported a position in AHCO in Q3 2021 and has held it in 19 quarters since. The position peaked at $10.1K in Q4 2023. 35 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • SignatureFD held 284 shares of AdaptHealth worth $2.96K as of Q2 2026.
  • SignatureFD bought 58 AdaptHealth shares in Q2 2026, an estimated $648.
  • AdaptHealth made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3042 holding.
  • SignatureFD first reported a position in AdaptHealth in Q3 2021 and has held it in 19 quarters since.
  • SignatureFD's AdaptHealth position peaked at $10.1K in Q4 2023.
  • 35 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.